Comparison of Finasteride (Proscar) and Serenoa Repens (Permixon) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers

This study compared the effectiveness of finasteride and Permixon in inhibiting 5-alpha reductase in healthy male volunteers. Finasteride was found to be more effective than Permixon in reducing serum dihydrotestosterone levels, confirming its potent and specific inhibition of 5-alpha reductase. The study suggests that finasteride may be a more effective treatment for conditions related to 5-alpha reductase, such as benign prostatic hyperplasia.